Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression - PubMed (original) (raw)
Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression
R J Pomerantz et al. J Exp Med. 1990.
Abstract
Lipopolysaccharide (LPS) potently stimulates human immunodeficiency virus type 1-long terminal repeat (HIV-1-LTR) CAT constructs transfected into monocyte/macrophage-like cell lines but not a T cell line. This effect appears to be mediated through the induction of nuclear factor kappa B (NF-kappa B). Electrophoretic mobility shift assays demonstrate that LPS induces a DNA binding activity indistinguishable from NF-kappa B in U937 and THP-1 cells. LPS is also shown to dramatically increase HIV-1 production from a chronically infected monocyte/macrophage-like cloned cell line, U1, which produces very low levels of HIV-1 at baseline. The stimulation of viral production from this cell line occurs only if these cells are treated with granulocyte/macrophage colony-stimulating factor (GM-CSF) before treatment with LPS. This stimulation of HIV-1 production is correlated with an increase in the level of HIV-1 RNA and and activation of NF-kappa B. LPS is not able to induce HIV-1 production in a cloned T cell line. The effect of LPS on HIV-1 replication occurs at picogram per milliliter concentrations and may be clinically significant in understanding the variability of the natural history of HIV-1 infection.
Similar articles
- Heat shock induction of HIV production from chronically infected promonocytic and T cell lines.
Stanley SK, Bressler PB, Poli G, Fauci AS. Stanley SK, et al. J Immunol. 1990 Aug 15;145(4):1120-6. J Immunol. 1990. PMID: 1696294 - Vitamin E and alpha-lipoate: role in antioxidant recycling and activation of the NF-kappa B transcription factor.
Packer L, Suzuki YJ. Packer L, et al. Mol Aspects Med. 1993;14(3):229-39. doi: 10.1016/0098-2997(93)90009-3. Mol Aspects Med. 1993. PMID: 8264337 Review. - Accumulation of unintegrated circular viral DNA in monocytes and growth-arrested T cells following infection with HIV-1.
Sonza S, Kiernan RE, Maerz AL, Deacon NJ, McPhee DA, Crowe SM. Sonza S, et al. J Leukoc Biol. 1994 Sep;56(3):289-93. doi: 10.1002/jlb.56.3.289. J Leukoc Biol. 1994. PMID: 8083601 Review.
Cited by
- Leishmania induces survival, proliferation and elevated cellular dNTP levels in human monocytes promoting acceleration of HIV co-infection.
Mock DJ, Hollenbaugh JA, Daddacha W, Overstreet MG, Lazarski CA, Fowell DJ, Kim B. Mock DJ, et al. PLoS Pathog. 2012;8(4):e1002635. doi: 10.1371/journal.ppat.1002635. Epub 2012 Apr 5. PLoS Pathog. 2012. PMID: 22496656 Free PMC article. - The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
Duan L, Ozaki I, Oakes JW, Taylor JP, Khalili K, Pomerantz RJ. Duan L, et al. J Virol. 1994 Jul;68(7):4302-13. doi: 10.1128/JVI.68.7.4302-4313.1994. J Virol. 1994. PMID: 8207805 Free PMC article. - Activation of human monocyte--derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication in vitro at the level of gene expression.
Bernstein MS, Tong-Starksen SE, Locksley RM. Bernstein MS, et al. J Clin Invest. 1991 Aug;88(2):540-5. doi: 10.1172/JCI115337. J Clin Invest. 1991. PMID: 1907615 Free PMC article. - Retinoid-dependent restriction of human immunodeficiency virus type 1 replication in monocytes/macrophages.
Hanley TM, Kiefer HL, Schnitzler AC, Marcello JE, Viglianti GA. Hanley TM, et al. J Virol. 2004 Mar;78(6):2819-30. doi: 10.1128/jvi.78.6.2819-2830.2004. J Virol. 2004. PMID: 14990701 Free PMC article.
References
- Anal Biochem. 1976 May 7;72:248-54 - PubMed
- J Exp Med. 1990 Jan 1;171(1):35-47 - PubMed
- Mol Cell Biol. 1982 Sep;2(9):1044-51 - PubMed
- Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 - PubMed
- Ann N Y Acad Sci. 1966 Jun 30;133(2):668-84 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous